Cannabis Central: Pure-Play Pot Stock Portfolio Performance For Monday, August 31st
The munKNEE.com Pure-Play Pot Stock Portfolio consists of the 25 pure-play* cannabis stocks that trade for more than US$1/share and it advanced 0.3% on Monday. 10 participants went UP, 13 went DOWN and 2 had no change in price. In addition, 3 of the 4 industry categories advanced. The details are as follows:
Major Winners
Only 2 stocks advanced by 5% or more, namely:
8 other stocks went up by less than 5% and 2 stocks had no change in price.
Major Losers
Only 2 stocks declined by 5% or more, namely:
11 other stocks declined by less than 5% in price.
The 25 munKNEE Pure-Play Pot Stock Portfolio participants operate in 4 categories based on their primary area of focus in the cannabis industry. The stocks within each category are identified below with how they did, on average, within each category:
- The Vertically Integrated (i.e. Seed-to-Sale) Category has 21 portfolio participants that grow, process, and sell cannabis and hemp flower and related products and they went UP .05%, on average.
- the 7 Canadian Licensed Producer (LPs) portfolio participants (ACB; APHA; CGC; CRON; OGI; ROMJF and TLRY) went DOWN 0.5%, on average.
- the 12 U.S. Multi-State Operator (MSOs) portfolio participants (ACRGF; AYRSF; CCHWF; CRLBF; CURLF; GTBIF; HRVSF; JUSHF; PLNHF; SHWZ; TCNNF and TRSSF) went UP 0.7%, on average.
- the 2 hemp seed-to-sale MSO portfolio participants (CWBHF and YCBD) went DOWN 4.6%, on average.
- The Extraction Category has 2 portfolio participants (NEPT and VLNCF) focused on the extraction of cannabis compounds and their infusion into consumer products and they went UP 0.2%, on average.
- The Consumption Devices Category has only 1 portfolio participant (GNLN) focused on developing and selling personal consumption devices for cannabis consumers such as vape pens and inhalers and it went UP 15.4% after having gone DOWN 31.1% on Friday.
- The Biotechnology Category has only 1 portfolio participant (AVCNF) which markets new drugs utilizing cannabinoids (CBD) and it went DOWN 1.0%.
*Please note: The 25 pure-play stocks in the munKNEE.com Pure-Play Pot Stock Portfolio are just that, pure, deriving 100% of their revenue from the sale of recreational and medicinal cannabis and consumption-related products so as to reflect the true health of the marijuana industry in the U.S. and Canada.
Visit munKNEE.com and register to receive our free Market Intelligence Report newsletter (sample more